Baixar PDF
Artigo anterior
Voltar à página
If you have problems to see the content please click here
Outros usuários também visualizaram estes artigos
Experience using Imatinib and then Nilotinib, as second line, in patient with chronic myeloid leukemia and previous bariatric surgery. A case report
Renato Centrone; Marcelo Bellesso; Debora Bonito; Daniela Dias; Rodrigo Santucci; Milton Aranha; Adelson Alves;
Hematol Transfus Cell Ther. 2020;42:373-5
Challenges in the production of COVID-19 convalescent plasma- analysis of donor recruitment
Eliseo Joji Sekiya; Marcelo Bellesso; Adelson Alves;
Hematol Transfus Cell Ther. 2021;43:382-4
THE OUTCOME OF PERIPHERAL T-CELL LYMPHOMA PATIENTS FAILING FIRST-LINE THERAPY, FROM PROSPECTIVE COHORT OF T-CELL BRAZIL PROJECT
Carmino De Souza; Eliana Miranda; Jamila Tavares; Renata LR Baptista; Karin C Cecyn; Juliana Pereira; Marcelo Bellesso; Samuel S Medina; Davimar Borducchi; Frederico L Nogueira; Daniela FC Farias; Thais Fischer; Rony Schaffel; Massimo Federico; Carlos S Chiattone;
Hematol Transfus Cell Ther. 2023;45 Supl 3:S13-4